It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.

by Abigail M. Johnston

Forward Look

Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.

by Tara Haelle

Forward Look

Adding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.

by Kris Conner

Forward Look

A clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.

by Ashley P. Taylor

Forward Look

Pretzel-shaped device delivers sustained doses of chemotherapy to the bladder

by Leah Lawrence

Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.

by Kendall K. Morgan

Survivor Profile

Initially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.

by Queen Muse

Healthy Habits

A daily tea habit is associated with improved survival for those with colorectal cancer.

by Anne Danahy

Q&A

Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.

by Marci A. Landsmann

Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.

by Sandra Gordon